Gemcitabine Plus Cisplatin Split Versus Gemcitabine Plus Carboplatin for Advanced Urothelial Cancer With Cisplatin-unfit Renal Function

Background: Combination chemotherapy with gemcitabine and cisplatin is the standard first-line treatment for advanced urinary tract urothelial cancer. Carboplatin is often substituted for cisplatin in patients who are cisplatin-ineligible, such as those with a glomerular filtration rate less than 60...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:In Vivo
Huvudupphovsmän: IZUMI, KOUJI, IWAMOTO, HIROAKI, YAEGASHI, HIROSHI, SHIGEHARA, KAZUYOSHI, NOHARA, TAKAHIRO, KADONO, YOSHIFUMI, MIZOKAMI, ATSUSHI
Materialtyp: Artigo
Språk:Inglês
Publicerad: International Institute of Anticancer Research 2019
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6364082/
https://ncbi.nlm.nih.gov/pubmed/30587618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11454
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk